Elsevier Business Intelligence (EBI) to Host 'Investment in Innovation (IN3) Medical Device 360° Summit-San Francisco,' October 15-17, 2012
Opening Presentation by Mark Leahey, President & CEO, MDMA, "The 2012 Elections: Impact on FDA, Healthcare Reform and the Future of Medical Technology Innovation"
(firmenpresse) - SAN FRANCISCO, CA -- (Marketwire) -- 07/09/12 -- , publisher of "The Gray Sheet" and the medtech industry's leading provider of strategic partnership and investment conferences, will host the strategic partnering and investment conference on , at the . Taking place in the hub of device investment and innovation in the Bay Area, the event will bring together a diverse group of medtech's key thought leaders -- from Corporate Business Development, Venture Capital and Strategic Investment, Start-Up Entrepreneurs and Industry Pioneers -- to candidly discuss the critical issues that will define the future of all players in the evolving device space.
will feature presentations by more than 25 early development- to commercial-stage start-up device companies seeking funding and/or strategic partnership, and an outstanding agenda of expert guest speakers and panels. In addition to the timely opening presentation -- "The 2012 Elections: Impact on FDA, Healthcare Reform and the Future of Medical Technology Innovation" by Mark Leahey, President and CEO, Medical Device Manufacturers Association (MDMA) -- Summit-San Francisco also will feature , internationally recognized cardiovascular surgeon, inventor and entrepreneur, who will host a Fireside Chat. Additionally, a special evening presentation will be given by , President, : Insightful panel topics will include: "; "; and, " Investors confirmed to participate to date include senior-level dealmakers from , , , , , , , , , and , among many others. Partnering software will be available to all registered attendees prior to the conference so that one-on-one on-site meetings can be pre-arranged.
This two-day special event will benefit anyone with a stake in the medical device sector: start-ups seeking investment or strategic partnership, investment firms, VCs, mid-size and large device manufacturers, and service providers. Emerging medtech companies that would like to apply to present in San Francisco should contact at 949-797-7142, or email .
Event co-sponsors include , , , and . Visit for full conference and registration details.
Elsevier Business Intelligence (EBI), an Elsevier company built on the heritage of F-D-C Reports, Windhover Information and Medtech Insight, is a global information supplier providing business intelligence on regulatory, business and reimbursement issues that are vital to the healthcare industry. Through a range of products including publications, conferences, and reports, EBI places biopharma and medical device professionals, and those who focus on these industries, at the forefront of knowledge, by providing the perfect combination of news and information together with penetrating insight and analysis. EBI () has offices in the U.S. in Bridgewater, N.J.; Norwalk, Conn.; Rockville, Md.; and Irvine, Calif.
Contact:
Ronald Trahan, APR
Ronald Trahan Associates Inc.
508-359-4005, x108
Themen in dieser Pressemitteilung:
Unternehmensinformation / Kurzprofil:
Datum: 09.07.2012 - 07:00 Uhr
Sprache: Deutsch
News-ID 1131020
Anzahl Zeichen: 0
contact information:
Contact person:
Town:
SAN FRANCISCO, CA
Phone:
Kategorie:
Venture Capital
Anmerkungen:
Diese Pressemitteilung wurde bisher 193 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Elsevier Business Intelligence (EBI) to Host 'Investment in Innovation (IN3) Medical Device 360° Summit-San Francisco,' October 15-17, 2012
"
steht unter der journalistisch-redaktionellen Verantwortung von
Elsevier Business Intelligence (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
